PHVS Pharvaris N.V. Ordinary Shares Loading... : Bullish and Bearish Analyst Opinions

Loading chart...
Top Calls
Feed
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
All Content
Source feeds
Buzzberg Top 50
All market capsNo capitalization filter
200 B and aboveMega
10 B to 200 BLarge
2 B to 10 BMid
0 to 2 BSmall
Custom
Enter market cap range in B USD
All directions
▲ Long
▼ Short
⛔ Avoid
✂ Close
◦ Others
Any score
LOW+
MED+
HIGH
? ?
12:53
Aug 17
seedy19tron Biotech trader, L/S
Reports widest ownership across specialist funds
"Reports widest Q2 2026 ownership across 95 specialist funds based on 13F filings, no directional view."
PHVS
MED
11:58
Aug 17
seedy19tron Biotech trader, L/S
Reports widest Q2 ownership among specialist funds
Reports the widest Q2 2026 ownership across 93 specialist funds based on 13F filings.
PHVS
MED
14:22
Aug 14
seedy19tron Biotech trader, L/S
Author expresses bullish conviction on VERA, NKTR, KOD.
Author expresses bullish conviction on VERA, NKTR, KOD, and BCRX with added positions and price targets, while framing ABVX, XBI, PHVS, and CCCC as watch items tied to catalysts.
PHVS
11:14
Aug 05
seedy19tron Biotech trader, L/S
Author notes raised guidance and potential upside if PHVS disappoints.
Author notes raised guidance and potential upside if PHVS disappoints, while referencing BCRX earnings beat without taking a clear position.
PHVS
LOW
14:25
May 15
A May MD Biotech investor
Long PHVS because the filing confirms sustained ODT demand.
Long PHVS because the filing confirms sustained ODT demand, directly benefiting PHVS's oral treatment franchise.
PHVS
HIGH

About PHVS Analyst Coverage

Buzzberg tracks PHVS (Pharvaris N.V. Ordinary Shares) across 2 sources. 0 bullish vs 0 bearish calls from 2 analysts. Sentiment: evenly split. 5 total trade ideas tracked. Past 7 days: 2 watch. Latest voices: seedy19tron, A May MD.